CinCor Pharma
Mason W. Freeman has 30 years of experience as a practicing physician and drug developer. He was most recently with Mass General Hospital (MGH) and 5AM Ventures.
This person is not in any offices
CinCor Pharma
CinCor is a clinical-stage cardiorenal therapeutics company with a novel clinical-stage candidate, CIN-107 that has the potential to dramatically expand therapeutic options for patients suffering from hypertension and its associated risks.